Found 0 matching trials
Efficacy and Safety of Pasireotide Long Acting Release vs. Octreotide Long Acting Release in Patients With Metastatic Carcinoid Disease
PHASE3The purpose of this randomized, multicenter, Phase III study was to compare...
Location
Scottsdale Healthcare/TGen Clinical Research Service TGen Clinical Research Service
Study to Evaluate the Efficacy and Safety of Lutathera in Patients With Grade 2 and Grade 3 Advanced GEP-NET
PHASE3The aim of NETTER-2 was to determine if Lutathera in combination with long-...
Status
Active Not Recruiting
Location
Yale Cancer Center
Efficacy and Safety of Pasireotide LAR (Long-acting Release) in Japanese Patients With Acromegaly or Pituitary Gigantism
PHASE2To evaluate efficacy, safety, pharmacokinetics and pharmacodynamics of pasi...
Location
Novartis Investigative Site
Pasireotide LAR Therapy of Silent Corticotroph Pituitary Tumors
PHASE2This is a phase II, open-label, 12-month pilot study in 10 patients with si...
Location
Neuroendocrine Unit and Pituitary Center, Columbia University
SOM 230 and Gemcitabine in Advanced Pancreatic Cancer
PHASE1The goal of this clinical research study is to learn if the study drug SOM ...
Location
H. Lee Moffitt Cancer Center and Research Institute
SOM230 LAR With Bortezomib and Dexamethasone for Refractory or Relapsed Multiple Myeloma
PHASE2The purpose of this study is to determine if adding SOM230 LAR to bortezomi...
Location
Hillman Cancer Center
Pasireotide LAR in Severe Polycystic Liver Disease
PHASE2The purpose of this study is to compare SOM230 treatment to placebo. The in...
Study of Pasireotide in Patients With Rare Tumors of Neuroendocrine Origin
PHASE2This study will assess the effectiveness and safety of pasireotide long-act...
Location
Cedars Sinai Medical Center Cedars Sinai 4
Pasireotide LAR and Pegvisomant Study in Acromegaly
PHASE4The objective of this study is to assess the efficacy of Pasireotide Long A...
Location
Erasmus Medical Center
Study of Pasireotide Long Acting Release (LAR) in Patients With Metastatic Neuroendocrine Tumors (NETs)
PHASE2The goal of this clinical research study is to learn if the study drug, Pas...
Location
Stanford Cancer Institute